ADVERTISEMENT
Vaccine illustration
Infographic: Inducing Active Immunity Against Opioid Overdose
How scientists aim to induce an immune response against addictive drugs
Infographic: Inducing Active Immunity Against Opioid Overdose
Infographic: Inducing Active Immunity Against Opioid Overdose

How scientists aim to induce an immune response against addictive drugs

How scientists aim to induce an immune response against addictive drugs

immunology, clinical trials, drug development

Illustration of a syringe with a person falling out of a bottle of pills
Opioid Vaccines as a Tool to Stem Overdose Deaths
Tori Rodriguez | Jun 13, 2022 | 10+ min read
Researchers are turning to the immune system for help in treating addiction and preventing overdose.
An illustration of a DNA double helix in gold with texture
Gene Therapy Continues to Benefit Kids with Immunodeficiency
Jef Akst | May 12, 2021 | 2 min read
Four dozen children with severe combined immunodeficiency (SCID) who received a corrective gene carried by a virus have working immune systems two to three years later, according to three independent clinical trials.
Antibody-Based Drug May Reduce COVID-19 Hospitalizations: Study
Lisa Winter | Sep 17, 2020 | 2 min read
Eli Lilly reports a 72 percent reduction in hospitalization risk among patients who received its monoclonal antibody compared to those who received a placebo.
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
Catherine Offord | Oct 14, 2019 | 2 min read
The move will allow the Belgium-headquartered biopharmaceutical giant to boost its work on treatments for rare diseases.
Opinion: Learning from Immunotherapy’s Recent Failures
Luis Felipe Campesato | Aug 1, 2018 | 6 min read
The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.
Toward Targeted Therapies for Autoimmune Disorders
Lawrence Steinman | Jun 1, 2016 | 10 min read
Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.
Clinical Trial Misfortune
Cristina Luiggi | Aug 28, 2012 | 1 min read
A human trial of a hepatitis C treatment is shut down after one of the participants died.
ADVERTISEMENT